MAPT and Mental deterioration: To the best of our knowledge, the sole study investigating the combined interaction of MCP-1 and β-amyloid [19] showed that, in the presence of abnormal CSF tau protein and Aβ42/P-tau ratio, increased levels of CSF MCP-1 exacerbated cognitive decline among MCI older adults.